News ReleaseView printer-friendly version
Quidel Corporation Names New Board Member
SAN DIEGO, Aug. 16 /PRNewswire/ -- Quidel Corporation (Nasdaq: QDEL) today announced the appointment of George W. Dunbar, Jr. to the company's Board of Directors, bringing the total number of Directors to eight. Mr. Dunbar most recently served as the President and Chief Executive Officer of Metra Biosystems, Inc., which became a wholly-owned subsidiary of Quidel as a result of a statutory merger completed August 5, 1999.
"We are pleased to have Mr. Dunbar join our Board. With his strong operating background in the life sciences, and specifically women's healthcare, we are confident that Mr. Dunbar will make a significant contribution to Quidel's women's health business," said Andre de Bruin, vice chairman, president and chief executive officer of Quidel Corporation.
Mr. Dunbar was President, Chief Executive Officer and Director of Metra Biosystems, Inc. since 1991. Prior to joining Metra, he was Vice President, Licensing and Business Development for The Ares-Serono Group, a Swiss healthcare company. Mr. Dunbar has over twenty-five years of experience in high technology fields and currently serves on the board of directors of LJL Biosystems, Sonus Pharmaceuticals and The Valley Medical Center Foundation.
Quidel Corporation discovers, develops, manufacturers and markets point-of-care rapid diagnostics for women's health and infectious diseases. These products provide simple, accurate and cost-effective diagnoses for acute and chronic conditions. Quidel's products are sold to professionals in the physician's office and clinical laboratory, and to consumers through organizations that provide private label, store brand products. For more information on Quidel, please visit the web site at http://www.quidel.com.
Charles J. Cashion, Chief Financial Officer, 619-552-7962,
or Christa Cerciello, Manager, Investor Relations, 619-646-8031,
both of Quidel Corporation